Revenue
$1.9B
▲ 40.3% YoY
Net Income
-$85.5M
▼ 98.9% YoY
EPS
-
Cash
$78.3M
▼ 59.8% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
THORNTON JOSEPH CLAY Interim CFO | Sell | Aug 17, 2026 | 17.8K | $4.39 | $78K | Form 4 ↗ |
Soares Karen Chief Legal Officer | Grant | Aug 12, 2026 | 108.7K | $0.00 | $0 | Form 4 ↗ |
THORNTON JOSEPH CLAY Interim CFO | Grant | Aug 12, 2026 | 54.3K | $0.00 | $0 | Form 4 ↗ |
Toy Andrew Chief Executive Officer | Sell | Aug 10, 2026 | 87.8K | $4.65 | $408K | Form 4 ↗ |
Soares Karen Chief Legal Officer | Sell | Jul 20, 2026 | 51.7K | $4.51 | $233K | Form 4 ↗ |
Reynoso Jamie L. CEO, Medicare Advantage | Sell | Jul 17, 2026 | 4.8K | $4.53 | $22K | Form 4 ↗ |
Toy Andrew Chief Executive Officer | Sell | Jul 15, 2026 | 62.7K | $4.67 | $293K | Form 4 ↗ |
Wai Conrad CEO, Counterpart Health | Sell | Jul 15, 2026 | 24.2K | $4.67 | $113K | Form 4 ↗ |
Reynoso Jamie L. CEO, Medicare Advantage | Sell | Jul 15, 2026 | 13.1K | $4.67 | $61K | Form 4 ↗ |
Soares Karen Chief Legal Officer | Sell | Jul 15, 2026 | 10.5K | $4.67 | $49K | Form 4 ↗ |
THORNTON JOSEPH CLAY Interim CFO | Sell | Jul 15, 2026 | 4.6K | $4.67 | $22K | Form 4 ↗ |
Reynoso Jamie L. CEO, Medicare Advantage | Sell | Jul 8, 2026 | 2.4K | $4.68 | $11K | Form 4 ↗ |